The Enterprise Value as of November 2024 (TTM) for Can-Fite BioPharma Ltd. (CANF) is 10.51M

According to Can-Fite BioPharma Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 10.51M. This represents a change of -99.73% compared to the average of 3.86B of the last 4 quarters.

Can-Fite BioPharma Ltd. (CANF) Historical Enterprise Value (quarterly & annually)

How has CANF Enterprise Value performed in the past?

The mean historical Enterprise Value of Can-Fite BioPharma Ltd. over the last ten years is 6.69B. The current 10.51M Enterprise Value has changed -84.29% with respect to the historical average. Over the past ten years (40 quarters), CANF's Enterprise Value was at its highest in in the September 2015 quarter at 13.36B. The Enterprise Value was at its lowest in in the September 2019 quarter at 1.88B.

Can-Fite BioPharma Ltd. (CANF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Can-Fite BioPharma Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Can-Fite BioPharma Ltd. (CANF) Average Enterprise Value

How has CANF Enterprise Value performed in the past?

The current Enterprise Value of Can-Fite BioPharma Ltd. (CANF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Can-Fite BioPharma Ltd. (CANF) Enterprise Value vs. Peers

How is CANF’s Enterprise Value compared to its peers?

Can-Fite BioPharma Ltd.’s Enterprise Value is less than ImmuCell Corporation (42.63M), less than Compugen Ltd. (137.99M), greater than Evogene Ltd. (2.54M), less than CollPlant Biotechnologies Ltd. (26.73M), less than Protalix BioTherapeutics, Inc. (96.89M), less than Corvus Pharmaceuticals, Inc. (550.07M), less than Aldeyra Therapeutics, Inc. (292.41M), less than Gamida Cell Ltd. (57.65M), less than Checkpoint Therapeutics, Inc. (149.72M), less than Candel Therapeutics, Inc. (163.63M), greater than BioRestorative Therapies, Inc. (8.21M), less than XTL Biopharmaceuticals Ltd. (16.34M), less than Cingulate Inc. (11.61M), greater than Adial Pharmaceuticals, Inc. (3.15M), greater than TransCode Therapeutics, Inc. (5.76M), less than Aditxt, Inc. (12.23M), less than Reviva Pharmaceuticals Holdings, Inc. (28.64M), greater than Avenue Therapeutics, Inc. (-1770008.00), less than BiondVax Pharmaceuticals Ltd. (22.07M), less than Oramed Pharmaceuticals Inc. (167.97M), less than MediWound Ltd. (201.88M), less than BioLineRx Ltd. (59.04M),

Build a custom stock screener for Can-Fite BioPharma Ltd. (CANF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Can-Fite BioPharma Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Can-Fite BioPharma Ltd. (CANF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Can-Fite BioPharma Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.